Alnylam Pharmaceuticals (ALNY) Debt Ratio (2016 - 2025)

Alnylam Pharmaceuticals (ALNY) has reported Debt Ratio for 9 consecutive years, with 0.03 the latest figure, recorded in Q3 2025.

• For the quarter ending Q3 2025, Debt Ratio changed N/A year-over-year to 0.03; the trailing twelve-month figure through Sep 2025 stood at 0.03 (changed N/A YoY), and the FY2024 full-year result was 0.02, changed N/A from the prior year.
• Debt Ratio slipped to 0.03 in Q3 2025 per ALNY's latest filing, from 0.03 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.2 in Q2 2022 and bottomed at 0.02 in Q4 2024.
• Historically, Debt Ratio has averaged 0.1 across 4 years, with a median of 0.09 in 2021.
• The widest YoY moves for Debt Ratio: up 234.87% in 2022, down 64.87% in 2022.
• Over 4 years, Debt Ratio stood at 0.19 in 2021, then gained by 9.72% to 0.2 in 2022, then plunged by 89.13% to 0.02 in 2024, then advanced by 13.01% to 0.03 in 2025.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.03, 0.03, and 0.03 for Q3 2025, Q2 2025, and Q1 2025 respectively.